ZSCAN21 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 6.203400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
7.949200E-01
Normal-vs-Stage2
4.596600E-01
Normal-vs-Stage3
1.588790E-01
Normal-vs-Stage4
8.559000E-01
Stage1-vs-Stage2
3.522000E-01
Stage1-vs-Stage3
2.277200E-01
Stage1-vs-Stage4
8.511600E-01
Stage2-vs-Stage3
3.219800E-01
Stage2-vs-Stage4
3.004800E-01
Stage3-vs-Stage4
1.405640E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
6.672600E-01
Normal-vs-AfricanAmerican
7.075400E-01
Normal-vs-Asian
3.160400E-02
Caucasian-vs-AfricanAmerican
8.352800E-01
Caucasian-vs-Asian
1.168490E-02
AfricanAmerican-vs-Asian
6.796100E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
5.184600E-01
Normal-vs-Female
7.111400E-01
Male-vs-Female
6.193400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
5.608400E-01
Normal-vs-Age(41-60Yrs)
9.432000E-01
Normal-vs-Age(61-80Yrs)
4.035800E-01
Normal-vs-Age(81-100Yrs)
7.723800E-02
Age(21-40Yrs)-vs-Age(41-60Yrs)
2.222400E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
4.024600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
3.887800E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
3.518500E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
3.138100E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
7.377800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
9.382200E-02
Normal-vs-Daily Drinker
5.037200E-01
Normal-vs-Weekly Drinker
4.208600E-01
Normal-vs-Occasional Drinker
9.641000E-01
Normal-vs-Social Drinker
8.312800E-01
Non Drinker-vs-Daily Drinker
4.835800E-01
Non Drinker-vs-Weekly Drinker
3.360800E-01
Non Drinker-vs-Occasional Drinker
2.257600E-01
Non Drinker-vs-Social Drinker
1.971560E-02
Daily Drinker-vs-Weekly Drinker
9.252800E-01
Daily Drinker-vs-Occasional Drinker
4.118000E-01
Daily Drinker-vs-Social Drinker
3.144800E-01
Weekly Drinker-vs-Occasional Drinker
4.405600E-01
Weekly Drinker-vs-Social Drinker
3.184000E-01
Occasional Drinker-vs-Social Drinker
8.169800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
2.454800E-01
Normal-vs-Grade 2
2.197800E-02
Normal-vs-Grade 3
2.029400E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
2.844600E-01
Grade 1-vs-Grade 3
9.300000E-01
Grade 1-vs-Grade 4
2.454800E-01
Grade 2-vs-Grade 3
1.894400E-01
Grade 2-vs-Grade 4
2.197800E-02
Grade 3-vs-Grade 4
2.029400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
1.722970E-01
Normal-vs-NonDiabetic
7.806600E-01
Diabetic-vs-NonDiabetic
1.994470E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
6.607200E-01
Normal-vs-NoPancreatitis
6.376800E-01
Pancreatitis-vs-NoPancreatitis
7.161000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
6.812400E-01
Normal-vs-N1
5.238200E-01
N0-vs-N1
4.538000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
7.726800E-01
Normal-vs-TP53-NonMutant
9.888200E-01
TP53-Mutant-vs-TP53-NonMutant
3.007800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
